Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
kerala ayurveda ltd. stock

KERALA AYURVEDA LTD. Share Price

312.1 14.39 (4.83%)
Nov 21 2024 03:30 PM Pharmaceuticals NSE: KERALAYUR

KERALA AYURVEDA LTD. Share Price Update

As of the latest trading session, KERALA AYURVEDA LTD. share price is currently at 312.1, which is up by 14.39 from its previous closing. Today, the stock has fluctuated between 300.10 and 312.55. Over the past year, KERALA AYURVEDA LTD. has achieved a return of 27.49 %. In the last month alone, the return has been 12.10 %. Read More...

KERALA AYURVEDA LTD. Performance

Day Range

Low300.10 High312.55
312.10

52 Week Range

Low 228.85 High 417.00
312.10

KERALA AYURVEDA LTD. Share Price

530163

KERALAYUR

img img img img
No Data Available

Open Price

311.00

Prev. Close

297.70

Volume (Shares)

19593.00

Total traded value

61.03

Upper Circuit

312.55

Lower Circuit

282.85

Note: The current prices & values are delayed, Login to your account for live updates.

KERALA AYURVEDA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 375.53
PE Ratio (TTM) -133.38
Book Value / Share 33.82
Beta 0.65
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.54

KERALA AYURVEDA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 18.60
Operating Expense 19.70
Net Profit -0.54
Net Profit Margin (%) -2.90
Earnings Per Share (EPS) -0.38
EBITDA -0.15
Effective Tax Rate (%) 23.94
Particulars JUN 2024 (Values in Cr)
Revenue 15.40
Operating Expense 17.40
Net Profit -1.29
Net Profit Margin (%) -8.37
Earnings Per Share (EPS) -1.01
EBITDA -1.14
Effective Tax Rate (%) 24.85
Particulars MAR 2024 (Values in Cr)
Revenue 17.05
Operating Expense 17.15
Net Profit -0.72
Net Profit Margin (%) -4.22
Earnings Per Share (EPS) -0.81
EBITDA 1.30
Effective Tax Rate (%) -77.49
Particulars DEC 2023 (Values in Cr)
Revenue 17.28
Operating Expense 17.49
Net Profit -0.27
Net Profit Margin (%) -1.56
Earnings Per Share (EPS) -0.18
EBITDA 0.54
Effective Tax Rate (%) -107.69
Particulars SEP 2023 (Values in Cr)
Revenue 17.61
Operating Expense 17.66
Net Profit 0.51
Net Profit Margin (%) 2.89
Earnings Per Share (EPS) 1.05
EBITDA 1.31
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 67.85
Operating Expense 67.78
Net Profit -0.27
Net Profit Margin (%) -0.39
Earnings Per Share (EPS) -0.25
EBITDA 5.02
Effective Tax Rate (%) 162.79
Particulars MAR 2023 (Values in Cr)
Revenue 59.12
Operating Expense 59.64
Net Profit 2.89
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 3.09
EBITDA 7.45
Effective Tax Rate (%) -21.94
Particulars MAR 2022 (Values in Cr)
Revenue 51.72
Operating Expense 50.79
Net Profit 0.89
Net Profit Margin (%) 1.72
Earnings Per Share (EPS) 1.17
EBITDA 7.88
Effective Tax Rate (%) 28.45
Particulars MAR 2021 (Values in Cr)
Revenue 40.10
Operating Expense 46.84
Net Profit -4.95
Net Profit Margin (%) -12.34
Earnings Per Share (EPS) -4.38
EBITDA 0.28
Effective Tax Rate (%) 24.77
Particulars MAR 2020 (Values in Cr)
Revenue 50.08
Operating Expense 49.01
Net Profit 0.88
Net Profit Margin (%) 1.75
Earnings Per Share (EPS) 1.12
EBITDA 3.12
Effective Tax Rate (%) 27.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.73
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.71
EBITDA Margin 6.74
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.18
EBITDA Margin 3.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5.79
ROE % 13.28
ROCE % 9.31
Total Debt to Total Equity 15.40
EBITDA Margin 12.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.42
EBITDA Margin 1.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.51
ROE % 17.88
ROCE % 6.60
Total Debt to Total Equity 10.80
EBITDA Margin 9.61
Particulars MAR 2024 (Values in Cr)
Book Value / Share 35.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.20
EBITDA Margin 7.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.77
ROE % 2.03
ROCE % 4.85
Total Debt to Total Equity 4.84
EBITDA Margin 7.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.68
ROE % 5.44
ROCE % 8.40
Total Debt to Total Equity 5.97
EBITDA Margin 14.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.51
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.01
EBITDA Margin 0.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.90
ROE % 3.89
ROCE % 2.94
Total Debt to Total Equity 4.05
EBITDA Margin 6.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 22.79
Total Assets 140.70
Total Liabilities 140.70
Total Equity 35.13
Share Outstanding 12032451
Price to Book Ratio 7.42
Return on Assets (%) -1.08
Return on Capital (%) -1.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.19
Total Assets 114.71
Total Liabilities 114.71
Total Equity 7.88
Share Outstanding 10555670
Price to Book Ratio 6.06
Return on Assets (%) -0.78
Return on Capital (%) -1.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.87
Total Assets 110.31
Total Liabilities 110.31
Total Equity 7.94
Share Outstanding 10555670
Price to Book Ratio 7.32
Return on Assets (%) 2.14
Return on Capital (%) 3.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.55
Total Assets 114.48
Total Liabilities 114.48
Total Equity 5.20
Share Outstanding 10555670
Price to Book Ratio 5.40
Return on Assets (%) -4.23
Return on Capital (%) -5.91
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.36
Total Assets 102.96
Total Liabilities 102.96
Total Equity 9.72
Share Outstanding 10555670
Price to Book Ratio 2.63
Return on Assets (%) 3.78
Return on Capital (%) 5.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.47
Total Assets 124.05
Total Liabilities 124.05
Total Equity 42.37
Share Outstanding 12032451
Price to Book Ratio 7.42
Return on Assets (%) -0.21
Return on Capital (%) -0.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 98.70
Total Liabilities 98.70
Total Equity 14.53
Share Outstanding 10555670
Price to Book Ratio 6.06
Return on Assets (%) 2.92
Return on Capital (%) 3.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 91.69
Total Liabilities 91.69
Total Equity 11.27
Share Outstanding 10555670
Price to Book Ratio 7.32
Return on Assets (%) 0.97
Return on Capital (%) 1.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.07
Total Assets 96.22
Total Liabilities 96.22
Total Equity 10.04
Share Outstanding 10555670
Price to Book Ratio 5.40
Return on Assets (%) -5.14
Return on Capital (%) -6.51
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.90
Total Assets 93.60
Total Liabilities 93.60
Total Equity 14.66
Share Outstanding 10555670
Price to Book Ratio 2.63
Return on Assets (%) 0.93
Return on Capital (%) 1.21
Particulars MAR 2024 (Values in Cr)
Net Income 5.73
Cash from Operations 3.28
Cash from Investing -1.25
Cash from Financing 17.64
Net change in Cash 18.41
Free Cash Flow 4.40
Particulars MAR 2023 (Values in Cr)
Net Income 4.26
Cash from Operations 10.22
Cash from Investing -7.21
Cash from Financing -1.13
Net change in Cash 1.50
Free Cash Flow 16.41
Particulars MAR 2022 (Values in Cr)
Net Income 9.32
Cash from Operations -0.50
Cash from Investing -1.90
Cash from Financing -13.27
Net change in Cash -15.68
Free Cash Flow 2.34
Particulars MAR 2021 (Values in Cr)
Net Income -0.41
Cash from Operations 7.42
Cash from Investing -1.43
Cash from Financing 6.20
Net change in Cash 12.19
Free Cash Flow 8.46
Particulars MAR 2020 (Values in Cr)
Net Income 6.08
Cash from Operations 5.20
Cash from Investing -4.02
Cash from Financing 0.84
Net change in Cash 1.81
Free Cash Flow 8.54
Particulars MAR 2024 (Values in Cr)
Net Income 4.25
Cash from Operations -4.21
Cash from Investing -2.17
Cash from Financing 21.14
Net change in Cash 14.75
Free Cash Flow -3.51
Particulars MAR 2023 (Values in Cr)
Net Income 6.81
Cash from Operations 9.11
Cash from Investing -5.32
Cash from Financing -2.27
Net change in Cash 1.52
Free Cash Flow 10.05
Particulars MAR 2022 (Values in Cr)
Net Income 7.12
Cash from Operations 8.75
Cash from Investing 0.82
Cash from Financing -10.51
Net change in Cash -0.94
Free Cash Flow 11.05
Particulars MAR 2021 (Values in Cr)
Net Income -0.52
Cash from Operations -0.91
Cash from Investing -2.10
Cash from Financing 2.18
Net change in Cash -0.83
Free Cash Flow 0.03
Particulars MAR 2020 (Values in Cr)
Net Income 2.43
Cash from Operations 4.70
Cash from Investing -3.93
Cash from Financing 0.28
Net change in Cash 1.06
Free Cash Flow 7.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 280.20
  • 26 Days 273.70
  • 10 Days 277.20
  • 50 Days 282.70
  • 12 Days 276.00
  • 100 Days 295.30
  • 20 Days 272.00
  • 200 Days 280.80
297.70
PIVOT
First Resistance 297.70
Second Resistance 297.70
Third Resistance 297.70
First Support 297.70
Second Support 297.70
Third Support 297.70
RSI 71.12
MACD 2.28
Commodity Channel Index (CCI) 217.37
ADX 19.56
Williams % R 0.00

Over 1 Month

down

12.10

Over 3 Months

down

-7.54

Over 6 Months

down

0.21

Over 1 Year

down

27.49

Over 3 Years

down

61.02

Over 5 Years

down

45.91

KERALA AYURVEDA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KERALA AYURVEDA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.39
Promoter Holdings
58.57
FII
0.0
DII
0.02
Promoter Shares(Pledge Percentage)
13.36
Name Category Shares Shares%
Katra Holdings Ltd Shareholding of Promoter and Promoter Group 6493435.0 53.97
Porinju Veliyath Public Shareholding 623000.0 5.18
Katra Phytochem (india) Private Limited Shareholding of Promoter and Promoter Group 555000.0 4.61
Sanjiv Dhireshbhai Shah Public Shareholding 347826.0 2.89
Dheeraj Kumar Lohia Public Shareholding 244094.0 2.03
Anil Kumar K Public Shareholding 188967.0 1.57
Sashikanth Balachandar Public Shareholding 152030.0 1.26

KERALA AYURVEDA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KERALA AYURVEDA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KERALA AYURVEDA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kerala Ayurveda Ltd?

Answer Field

The share price of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and for BSE is ₹ 312.10.

What is the Market Cap of Kerala Ayurveda Ltd?

Answer Field

The market cap of Kerala Ayurveda Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 3,75.50 Cr. as of now.

What is the 52 Week High and Low of Kerala Ayurveda Ltd?

Answer Field

The 52 Week High and Low of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 417.00 and ₹ 224.70.

How to Buy Kerala Ayurveda Ltd share?

Answer Field

You can trade in Kerala Ayurveda Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kerala Ayurveda Ltd?

Answer Field

The 1 year returns on the stock has been 27.49%.

What is the Current Share Price of Kerala Ayurveda Ltd?

Answer Field

Kerala Ayurveda Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 312.10 as on Nov 21 2024 03:30 PM.

What is the Market Cap of Kerala Ayurveda Ltd Share?

Answer Field

The market cap of Kerala Ayurveda Ltd for NSE ₹ 0.0 & for BSE ₹ 3,75.50 as on Nov 21 2024 03:30 PM.

What is the P/E Ratio of Kerala Ayurveda Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM the price-to-earnings (PE) ratio for Kerala Ayurveda Ltd share is -133.38.

What is the PB ratio of Kerala Ayurveda Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM, the price-to-book (PB) ratio for Kerala Ayurveda Ltd share is 33.82.

How to Buy Kerala Ayurveda Ltd Share?

Answer Field

You can trade in Kerala Ayurveda Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kerala Ayurveda Ltd Share on Bajaj Broking App?

Answer Field

To buy Kerala Ayurveda Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kerala Ayurveda Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader